UCLA TECHs - LifeSci/Biotech

UCLA PATENTS AND INVENTIONS AVAILABLE FOR LICENSING

Engineered Antibody-quantum Dot Conjugates (ImmunoQdots) for Cancer Marker Detection

		By Bob Nidever in Latest Additions Published: Friday, 10 October 08 - 11:04 PM (GMT)

Researchers at UCLA have designed, engineered, and validated antibody-quantum dot conjugates (immunoQdots) for in vitro and in vivo detection of cancer cell markers by optical imaging.

Researchers at UCLA have modified quantum dots with tumor-specific engineered antibody fragments for in vitro and in vivo imaging of antigen surface markers on tumor cells. MORE [2008-659]
<-- Back